These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1414 related articles for article (PubMed ID: 33524158)

  • 1. Convalescent plasma for COVID-19 - encouraging signals of efficacy.
    Casadevall A; Tobian AAR
    Br J Haematol; 2021 Feb; 192(4):681-682. PubMed ID: 33524158
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 convalescent plasma: Interim recommendations from the AABB.
    Cohn CS; Estcourt L; Grossman BJ; Pagano MB; Allen ES; Bloch EM; Casadevall A; Devine DV; Dunbar NM; Foroutan F; Gniadek TJ; Goel R; Gorlin J; Joyner MJ; Metcalf RA; Raval JS; Rice TW; Shaz BH; Vassallo RR; Winters JL; Beaudoin G; Tobian AAR
    Transfusion; 2021 Apr; 61(4):1313-1323. PubMed ID: 33586160
    [No Abstract]   [Full Text] [Related]  

  • 3. Convalescent blood plasma (CBP) donated by recovered COVID-19 patients - A comment.
    Lung T; Sakem B; Risch M; Nydegger U
    Transfus Apher Sci; 2021 Jun; 60(3):103108. PubMed ID: 33678561
    [No Abstract]   [Full Text] [Related]  

  • 4. Longitudinal analysis of SARS-CoV-2 antibodies in 8000 U.S. first-time convalescent plasma donations.
    Karbiener M; Farcet MR; Ilk R; Schreiner J; Lenart J; Powers N; Stewart JM; Tallman H; Kreil TR
    Transfusion; 2021 Apr; 61(4):1141-1147. PubMed ID: 33615484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convalescent plasma as a treatment modality for coronavirus disease 2019 in Sudan.
    Hassan MO; Osman AA; Elbasit HEA; Hassan HE; Rufai H; Satti MMM; Elnegoumi M; Idris R; Musa A; Ali AH; Zroog SA; Altayb ADA; Khairy A; Allam M; Abdelhalim ATI
    Transfus Apher Sci; 2020 Dec; 59(6):102918. PubMed ID: 32900597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput detection of antibodies targeting the SARS-CoV-2 Spike in longitudinal convalescent plasma samples.
    Anand SP; Prévost J; Richard J; Perreault J; Tremblay T; Drouin M; Fournier MJ; Lewin A; Bazin R; Finzi A
    Transfusion; 2021 May; 61(5):1377-1382. PubMed ID: 33604922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of convalescent plasma for pediatric patients with SARS-CoV-2: A systematic literature review.
    Zaffanello M; Piacentini G; Nosetti L; Franchini M
    Transfus Apher Sci; 2021 Apr; 60(2):103043. PubMed ID: 33388249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 convalescent plasma therapy in pediatric patient after hematopoietic stem cell transplantation.
    Balashov D; Trakhtman P; Livshits A; Kovalenko I; Tereshenko G; Solopova G; Petraikina E; Maschan A; Novichkova G
    Transfus Apher Sci; 2021 Feb; 60(1):102983. PubMed ID: 33153902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Google Trends demonstrate public interest in COVID-19 convalescent plasma therapy.
    Adkins BD; Booth GS
    J Clin Apher; 2021 Jun; 36(3):492-493. PubMed ID: 33340373
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of high-titer anti-SARS-CoV-2 human convalescent plasma in high-risk children.
    Gordon O; Brosnan MK; Yoon S; Jung D; Littlefield K; Ganesan A; Caputo CA; Li M; Morgenlander WR; Henson SN; Ordonez AA; De Jesus P; Tucker EW; Peart Akindele N; Ma Z; Wilson J; Ruiz-Bedoya CA; Younger MEM; Bloch EM; Shoham S; Sullivan D; Tobian AA; Cooke KR; Larman B; Gobburu JV; Casadevall A; Pekosz A; Lederman HM; Klein SL; Jain SK
    JCI Insight; 2022 Jan; 7(2):. PubMed ID: 34855624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of SARS-CoV-2-independent immunoregulatory activity of COVID-19 convalescent plasma.
    Brox R; Achenbach S; Hackstein H
    Transfusion; 2021 Nov; 61(11):3087-3093. PubMed ID: 34546583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in serum antibodies to SARS-CoV-2 in convalescent plasma donors over time.
    Prus K; Alquist CR; Cancelas JA; Oh D
    Transfusion; 2021 Feb; 61(2):651-654. PubMed ID: 33616966
    [No Abstract]   [Full Text] [Related]  

  • 13. Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19.
    Van Damme KFA; Tavernier S; Van Roy N; De Leeuw E; Declercq J; Bosteels C; Maes B; De Bruyne M; Bogaert D; Bosteels V; Hoste L; Naesens L; Maes P; Grifoni A; Weiskopf D; Sette A; Depuydt P; Van Braeckel E; Haerynck F; Lambrecht BN
    Front Immunol; 2020; 11():596761. PubMed ID: 33329586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convalescent plasma to treat COVID-19: clinical experience and efficacy.
    Pei S; Yuan X; Zhang Z; Yao R; Xie Y; Shen M; Li B; Chen X; Yin M
    Aging (Albany NY); 2021 Mar; 13(6):7758-7766. PubMed ID: 33735836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convalescent plasma treatment of critically ill intensive care COVID-19 patients.
    Lindemann M; Lenz V; Knop D; Klump H; Alt M; Aufderhorst UW; Schipper L; Schwarzkopf S; Meller L; Steckel N; Koldehoff M; Heinold A; Heinemann FM; Fischer J; Hutschenreuter G; Knabbe C; Dolff S; Brenner T; Dittmer U; Witzke O; Herbstreit F; Horn PA; Krawczyk A
    Transfusion; 2021 May; 61(5):1394-1403. PubMed ID: 33784412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selecting COVID-19 convalescent plasma for neutralizing antibody potency using a high-capacity SARS-CoV-2 antibody assay.
    Goodhue Meyer E; Simmons G; Grebe E; Gannett M; Franz S; Darst O; Di Germanio C; Stone M; Contestable P; Prichard A; Reik R; Vassallo R; Young P; Busch MP; Williamson P; Dumont LJ
    Transfusion; 2021 Apr; 61(4):1160-1170. PubMed ID: 33554362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COVID-19: Still a place for the convalescent plasma? Focus on the immunocompromised patients].
    Richier Q; Hueso T; Tiberghien P; Lacombe K
    Rev Med Interne; 2023 Sep; 44(9):467-471. PubMed ID: 37689526
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is convalescent plasma an alternative treatment for Covid-19 patients?].
    Trejo-Gómor JE; Dimas-González J; Lagunas-Martínez A
    Salud Publica Mex; 2020; 62(6):870-871. PubMed ID: 33620985
    [No Abstract]   [Full Text] [Related]  

  • 19. Convalescent plasma for COVID-19 considerations.
    Adiwinata Pawitan J
    Transfus Apher Sci; 2021 Feb; 60(1):102927. PubMed ID: 32878733
    [No Abstract]   [Full Text] [Related]  

  • 20. A trend of dropping anti-SARS-CoV-2 plaque reduction neutralization test titers over time in Canadian convalescent plasma donors.
    Drews SJ; Devine DV; McManus J; Mendoza E; Manguiat K; Wood H; Girardin R; Dupuis A; McDonough K; Drebot M
    Transfusion; 2021 May; 61(5):1440-1446. PubMed ID: 33734448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.